{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:23:22Z","timestamp":1790659402936,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM131821"],"award-info":[{"award-number":["R35GM131821"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbapap.2025.141083","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:15:03Z","timestamp":1749654903000},"page":"141083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["HDAC7 influences ER-\u237a transcription via NCoR-HDAC3 dissociation"],"prefix":"10.1016","volume":"1873","author":[{"given":"Ishadi K.M.","family":"Kodikara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine O.","family":"Nwanelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela K.","family":"Belanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kay H.","family":"Pflum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2025.141083_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40572-013-0008-2","article-title":"Histone modification patterns and their responses to environment","volume":"1","author":"Dai","year":"2014","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.bbapap.2025.141083_bb0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1139\/o05-041","article-title":"Role of histone acetylation in the control of gene expression","volume":"83","author":"Verdone","year":"2005","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0015","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2025.141083_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051110","article-title":"Regulation of chemokines and cytokines by histone deacetylases and an update on histone decetylase inhibitors in human diseases","volume":"20","author":"Gatla","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbapap.2025.141083_bb0025","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bbapap.2025.141083_bb0030","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1158\/1078-0432.CCR-11-3144","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"18","author":"Prince","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0035","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: Belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0045","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1582-4934.2011.01321.x","article-title":"Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis","volume":"15","author":"Clocchiatti","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbapap.2025.141083_bb0050","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","article-title":"Class II histone deacetylases: from sequence to function, regulation, and clinical implication","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0055","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2025.141083_bb0060","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bmcl.2008.02.025","article-title":"Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases","volume":"18","author":"Jones","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2025.141083_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR","volume":"9","author":"Fischle","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2025.141083_bb0070","doi-asserted-by":"crossref","first-page":"35826","DOI":"10.1074\/jbc.M104935200","article-title":"Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo","volume":"276","author":"Fischle","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1162\u20131173","key":"10.1016\/j.bbapap.2025.141083_bb0075","article-title":"Evidence that HDAC7 acts as an epigenetic \u201creader\u201d of AR acetylation through NCoR-HDAC3 dissociation","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/ol.2022.13619","article-title":"HDAC7 inhibits cell proliferation via NudCD1\/GGH axis in triple-negative breast cancer","volume":"25","author":"Zhu","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbapap.2025.141083_bb0085","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1038\/s41388-019-0897-0","article-title":"HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells","volume":"38","author":"Caslini","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2025.141083_bb0090","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.celrep.2020.02.007","article-title":"Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2","volume":"30","author":"Das Gupta","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbapap.2025.141083_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/acschembio.4c00753","article-title":"Scaffolding activities of pseudodeacetylase HDAC7","volume":"20","author":"Kodikara","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbapap.2025.141083_bb0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio.1223","article-title":"Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group","volume":"9","author":"Lobera","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0115","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.febslet.2012.04.045","article-title":"The bromodomain interaction module","volume":"586","author":"Filippakopoulos","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbapap.2025.141083_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1097-2765(03)00482-9","article-title":"Selective recognition of acetylated histones by bromodomain proteins visualized in living cells","volume":"13","author":"Kanno","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2025.141083_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-006-9223-6","article-title":"Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation","volume":"294","author":"Peng","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0130","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1126\/science.288.5470.1422","article-title":"Structure and function of a human TAFII250 double Bromodomain module","volume":"288","author":"Jacobson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2025.141083_bb0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/jmbi.2000.4207","article-title":"Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain","volume":"304","author":"Hudson","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1097-2765(03)00528-8","article-title":"Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation","volume":"13","author":"Mujtaba","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbapap.2025.141083_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/wasj.2021.122","article-title":"An updated evolutionary study of the nuclear receptor protein family","volume":"3","author":"Papageorgiou","year":"2021","journal-title":"World Acad. Sci. J."},{"key":"10.1016\/j.bbapap.2025.141083_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156802606776173483","article-title":"Estrogen receptors as therapeutic targets in breast cancer","volume":"6","author":"Ariazi","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-023-00523-4","article-title":"An emerging generation of endocrine therapies in breast cancer: a clinical perspective","volume":"9","author":"Patel","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbapap.2025.141083_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/febs.16695","article-title":"Acetylation of nuclear receptors in health and disease: an update","volume":"291","author":"Ashton","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.bbapap.2025.141083_bb0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1210\/me.2005-0531","article-title":"Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor","volume":"20","author":"Kim","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0170","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/MCB.01002-09","article-title":"Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain","volume":"30","author":"Varlakhanova","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0175","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1073\/pnas.0804604105","article-title":"The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo","volume":"105","author":"Astapova","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2025.141083_bb0180","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/me.2005-0012","article-title":"Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate","volume":"19","author":"Wang","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0185","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1074\/jbc.M409468200","article-title":"The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis","volume":"280","author":"Yu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0190","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1074\/jbc.274.17.11713","article-title":"A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p","volume":"274","author":"Fischle","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0195","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/MCB.22.10.3373-3388.2002","article-title":"Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function","volume":"22","author":"Fu","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0200","doi-asserted-by":"crossref","first-page":"34809","DOI":"10.1074\/jbc.M112.372797","article-title":"Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation","volume":"287","author":"Su","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0205","doi-asserted-by":"crossref","first-page":"17519","DOI":"10.1016\/S0021-9258(19)85364-4","article-title":"Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors","volume":"268","author":"Kupfer","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ab.2019.04.022","article-title":"CYP26A1 gene promoter is a useful tool for reporting RAR-mediated retinoid activity","volume":"577","author":"Zolfaghari","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0215","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand-binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbapap.2025.141083_bb0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbapap.2025.141083_bb0225","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/nar\/29.14.2905","article-title":"Estrogen receptor interaction with estrogen response elements","volume":"29","author":"Klinge","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/MCB.00907-09","article-title":"Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM","volume":"30","author":"Malik","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0235","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1038\/s41388-018-0377-y","article-title":"GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer","volume":"37","author":"Hodgkinson","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbapap.2025.141083_bb0240","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/MCB.19.8.5504","article-title":"Histone deacetylase 1 can repress transcription by binding to Sp1","volume":"19","author":"Doetzlhofer","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0245","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/s41467-024-48724-0","article-title":"HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes","volume":"15","author":"Barrett","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2025.141083_bb0250","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/me.2005-0178","article-title":"Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha","volume":"19","author":"Leong","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.109.207084","article-title":"Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor","volume":"106","author":"van Rooij","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.11403","article-title":"Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha","volume":"107","author":"Kawai","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbapap.2025.141083_bb0265","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1158\/0008-5472.CAN-08-3458","article-title":"Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells","volume":"69","author":"Azuma","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbapap.2025.141083_bb0270","doi-asserted-by":"crossref","first-page":"18375","DOI":"10.1074\/jbc.M100800200","article-title":"Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2025.141083_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312111121","article-title":"Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation","volume":"121","author":"Cheung","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2025.141083_bb0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2007.05.002","article-title":"Disruption of HDAC4\/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression","volume":"74","author":"Matsuoka","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2025.141083_bb0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/msb.2013.26","article-title":"The functional interactome landscape of the human histone deacetylase family","volume":"9","author":"Joshi","year":"2013","journal-title":"Mol. Syst. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963925000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963925000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:29:05Z","timestamp":1753860545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963925000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1570963925000214"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2025.141083","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC7 influences ER-\u237a transcription via NCoR-HDAC3 dissociation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2025.141083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141083"}}